Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico / in vitro assessment
- 3 January 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Structure
- Vol. 1230, 129868
- https://doi.org/10.1016/j.molstruc.2020.129868
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Anti-SARS coronavirus agents: a patent review (2008 – present)Expert Opinion on Therapeutic Patents, 2013
- Pyrrolo[2,3-b]quinoxalines as inhibitors of firefly luciferase: Their Cu-mediated synthesis and evaluation as false positives in a reporter gene assayBioorganic & Medicinal Chemistry Letters, 2012
- Recent Advances in the Ultrasound-Assisted Synthesis of AzolesPublished by IntechOpen ,2012
- Efficient indoles and anilines syntheses employing tert-butyl sulfinamide as ammonia surrogateTetrahedron Letters, 2011
- 2,3-Disubstituted pyrrolo[2,3-b]quinoxalines via aminopalladation–reductive eliminationTetrahedron Letters, 2004
- GEMDOCK: A generic evolutionary method for molecular dockingProteins, 2004
- Ultrasound in synthetic organic chemistryChemical Society Reviews, 1997
- Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitorInternational Journal of Immunopharmacology, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Alkynyl- and dialkynyl-quinoxalines. Synthesis of condensed quinoxalinesJournal of the Chemical Society, Perkin Transactions 1, 1980